Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1973

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Effect of oral steroid contraceptives on mammary fibroadenoma. [Der

Einfluss oraler Steroidkontrazeptiva auf das Fibroadenom der Mamma.]

AUTHORS

Prechtel K; Seidel H

SOURCE

Deutsche Medizinische Wochenschrift 98(14): 698-702. April 6, 1973.

ABSTRACT

Biopsies were taken from 790 randomly selected women of childbearing age of whom 233 had been taking oral

contraceptives. Fibroadenomas were found in 61 of 233 women taking contraceptives and in 152 of 557 untreated

women, a similar incidence. It was concluded that 1) the incidence of fibroadenoma is no greater in women on oral

contraceptives than in untreated women; 2) fibroadenoma with marked intracanalicular epithelial proliferation is

slightly more common in women taking contraceptives, but fibroadenoma without much intracanalicular epithelial

proliferation is significantly less frequent; 3) in women with evidence of hormonal ovarian insufficiency, fibroadenoma

is less common if they have been taking contraceptives for a long time; and 4) any shift in frequency distribution due

to contraceptive treatment is observed after 1 year of medication, without further significant change after 2 or more

years.(AUTHORS', MODIFIED) (PubHealth.info Document ID: CONT8T 584-06)

PubHealth.info NOTE: The author(s) of this article titled, "Effect of oral steroid contraceptives on mammary

fibroadenoma. [Der Einfluss oraler Steroidkontrazeptiva auf das Fibroadenom der Mamma.]", is(are) Prechtel K;

Seidel H. The source of this article is "Deutsche Medizinische Wochenschrift 98(14): 698-702. April 6, 1973.". This

article was published in 1973 in German language(s). (PubHealth.info® Document ID: CONT8T 584-06. All rights

reserved with PubHealth.info) PIN: 35584

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.